+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04900935

Study of POISE Supportive Care Model for Adults with Metastatic Non-small Cell Lung Cancer on Targeted Therapy

Led by Massachusetts General Hospital · Updated on 2025-11-24

70

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a supportive care model called POISE for patients with metastatic Non-small Cell Lung Cancer NSCLC who have oncogenic driver mutations and are receiving targeted therapy. This study aims to see if POISE is feasible to deliver, acceptable to patients, and how it affects patients distress about their uncertain future, confidence in managing cancer, and understanding of what to expect. The POISE intervention includes four 60-minute sessions with specially trained palliative care clinicians who address psychosocial issues and promote health behaviors. Participants in the randomized controlled trial will either receive POISE or continue with usual oncology care, which may include standard palliative care if needed. The study involves an open pilot phase with 10 patients followed by a randomized phase with 60 patients. Participants will complete three surveys at baseline, 12 weeks, and 20 weeks after enrollment, and undergo chart reviews and an exit interview. Researchers will measure feasibility by enrollment rates and session and survey completions, along with acceptability, emotional coping, prognostic awareness, self-efficacy, and documentation of goals and values over 12 to 20 weeks. The total participation period is about 20 weeks.

CONDITIONS

Brief Title

Patient-centered, Optimal Integration of Survivorship and Palliative Care

Research Team

L

Laura A Petrillo, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here